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ABSTRACT 
Background and Aims: Celiac disease (CD) diagnosis is becoming more difficult as patients with no intestinal 
histology lesions may also be suffering from CD. The aim of the study was to evaluate the diagnostic 
accuracy of anti-endomysium (EmA) assay in the culture medium of intestinal biopsies for CD diagnosis.  
Patients and Methods: The clinical charts of 418 CD patients and 705 non-CD controls who had all 
undergone EmA assay in the culture medium were reviewed.  
Results: EmA assay in the culture medium had a higher sensitivity (98% vs 80%) and specificity (99% vs 
95%) than serum EmA/anti-tTG assay. Furthermore, during the follow-up, four patients with negative serum 
EmA/anti-tTG, normal villi architecture and positive EmAs in the culture medium, developed villous atrophy 
and underwent gluten-free diet with consequent resolution of the symptoms and complete intestinal histology 
recovery.  
Conclusion: EmA assay in the culture medium should be included in the diagnostic criteria for CD diagnosis 
in “seronegative” patients.  
 
 
 
 
 
 
